Labcorp Holdings Inc.
LH
$259.93
$4.181.63%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.54B | 3.52B | 3.56B | 3.53B | 3.35B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.54B | 3.52B | 3.56B | 3.53B | 3.35B |
| Cost of Revenue | 2.52B | 2.52B | 2.54B | 2.48B | 2.40B |
| Gross Profit | 1.01B | 993.20M | 1.03B | 1.05B | 948.00M |
| SG&A Expenses | 551.00M | 549.70M | 552.40M | 579.30M | 546.00M |
| Depreciation & Amortization | 75.60M | 72.60M | 69.50M | 68.30M | 69.60M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.15B | 3.14B | 3.16B | 3.13B | 3.01B |
| Operating Income | 387.20M | 370.90M | 403.20M | 398.60M | 332.40M |
| Income Before Tax | 319.70M | 190.60M | 337.00M | 304.70M | 275.20M |
| Income Tax Expenses | 41.70M | 25.70M | 75.50M | 66.40M | 62.20M |
| Earnings from Continuing Operations | 278.00M | 164.90M | 261.50M | 238.30M | 213.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -200.00K | -200.00K | -400.00K | -400.00K | -200.00K |
| Net Income | 277.80M | 164.70M | 261.10M | 237.90M | 212.80M |
| EBIT | 387.20M | 370.90M | 403.20M | 398.60M | 332.40M |
| EBITDA | 560.50M | 549.40M | 574.20M | 568.90M | 499.20M |
| EPS Basic | 3.38 | 2.00 | 3.14 | 2.85 | 2.55 |
| Normalized Basic EPS | 2.53 | 2.39 | 2.56 | 2.54 | 2.15 |
| EPS Diluted | 3.35 | 1.97 | 3.12 | 2.84 | 2.52 |
| Normalized Diluted EPS | 2.51 | 2.37 | 2.54 | 2.53 | 2.14 |
| Average Basic Shares Outstanding | 82.30M | 82.50M | 83.10M | 83.40M | 83.60M |
| Average Diluted Shares Outstanding | 82.90M | 83.20M | 83.70M | 83.90M | 84.30M |
| Dividend Per Share | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 |
| Payout Ratio | 22.03% | 36.00% | 22.94% | 25.18% | 28.95% |